Virtual DCAT Member Company Announcement Forum

Hear from companies making news at the Virtual DCAT Member Company Announcement Forum

Coming July 12, 2021, Exclusive Viewing for DCAT Member Companies

Stay in the know and get the latest developments from across the bio/pharmaceutical manufacturing value chain at the Virtual DCAT Member Company Announcement Forum.

CEOs and senior executives from DCAT member companies will be announcing key strategic company developments, including significant manufacturing expansions, mergers and acquisitions (M&A), and post-M&A activities as part of the Virtual DCAT Member Company Announcement Forum.

Pre-recorded video announcements from the selected companies* will be available to the DCAT membership from July 12, 2021 through July 31, 2021 via the DCAT member portal. Email communications and the DCAT Value Chain Insights e-newsletter will alert members of their availability.

Hear from these high-level executives from DCAT member companies (listed alphabetically):

Company Speaker
Aceto Gilles Cottier, CEO
Ajinomoto Bio-Pharma Services Dr. Mark Cassidy, CEO & President, Ajinomoto Bio-Pharma Services Europe
Asymchem Elut Hsu, President & Senior Vice President, Business Development
Benuvia Scott Watson, President
Boehringer Ingelheim Dr. Christian Eckermann, Senior Vice President, Biopharma Austria
Carbogen Amcis Mark Griffiths, Dishman Carbogen Amcis Group CEO
Catalent Karen Flynn, President, Biologics & Chief Commercial Officer
Cytiva Emmanuel Ligner, Danaher Group Executive & President and CEO, Cytiva
DSM Nutritional Products Kelsey Achenbach, Global Segment Director, Pharma & Medical Nutrition
Evonik Dr. Stefan Randl, Vice President, Research, Development & Innovation, Nutrition & Care, Health Care, Evonik
Frontida BioPharm Eric Kinzle, Ph.D., Study Director
Gerresheimer Niels Düring, Global Executive Vice President, Primary Packaging Plastics
Helsinn Advanced Synthesis Waldo Mossi, General Manager
LGM Pharma Prasad Raje, CEO
Lonza Christian Dowdeswell, Head of Commercial Development, Small Molecules
Ortec Christopher Brotherton, President
PharmaBlock Jing Li, Ph.D., Senior Vice President
Polpharma Shlomo Gang, General Director, Polpharma API
Rondo-Pak Bob Reilley, President & COO
Samsung Biologics Segang Park, Vice President, Team Leader, Engineering Project Management, EPCV
Sanofi US SAIS/EuroAPI Karl Rotthier, CEO, EuroAPI
Sterling Pharma Solutions Kevin Cook, CEO
Stevanato Group Mauro Stocchi, Chief Business Officer
Thermo Fisher Scientific  Leon Wyszkowski, President, Commercial Operations, Pharma Services
Valsynthese Mara Guzzetti, Ph.D., Senior Executive Vice President, Fine Chemicals
WuXI STA Yu Lu, Vice President, Business Operations, & Jinling Chen, Senior Vice President, Drug Product Division

* Participating companies submit applications describing news announcements, which must be on the following: (1) key corporate strategic developments made in 2021; (2) mergers and acquisitions (M&A), including post-M&A integration; or (3) significant manufacturing expansions, including updated timelines for completion and launch. Announcements made prior to January 2021 must include updated timelines in 2021 or beyond for manufacturing expansions or in the case of M&A announcements, updates of post-M&A integration. Applications are reviewed by the DCAT Oversight Task Force, composed of volunteers from DCAT member companies, and are selected for participation based on meeting content and presentation criteria.